Ronald Yanagihara
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pharmacology top 5%
- Co-authors
- Lee S. RosenDavid GordonVera HirshMing ZhengGladys UrbanowitzPaul de SouzaMaciej KrzakowskiMarek Pawlicki
- Topics
- Lung Cancer Treatments and Mutations (6 papers)Bone health and treatments (4 papers)Colorectal Cancer Treatments and Studies (3 papers)
- Partner nations
- United StatesPolandAustralia
In The Last Decade
Ronald Yanagihara
17 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 584
- Surgery 398
- Radiology, Nuclear Medicine and Imaging 377
- Pharmacology 269
Countries citing papers authored by Ronald Yanagihara
This map shows the geographic impact of Ronald Yanagihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Yanagihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Yanagihara more than expected).
Fields of papers citing papers by Ronald Yanagihara
This network shows the impact of papers produced by Ronald Yanagihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Yanagihara. The network helps show where Ronald Yanagihara may publish in the future.
Co-authorship network of co-authors of Ronald Yanagihara
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Yanagihara. A scholar is included among the top collaborators of Ronald Yanagihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Yanagihara. Ronald Yanagihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 8 | |
| 3 | 12 | |
| 4 | 3 | |
| 5 | 14 | |
| 6 | 2 | |
| 7 | 291 | |
| 8 | 26 | |
| 9 | 45 | |
| 10 | 45 | |
| 11 | 81 | |
| 12 | Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumorsbreakdown → | 507 |
| 13 | 63 | |
| 14 | Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Groupbreakdown → | 557 |
| 15 | 6 | |
| 16 | 16 | |
| 17 | 22 |
About Ronald Yanagihara
Ronald Yanagihara is a scholar working on Oncology, Anesthesiology and Pain Medicine and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Bone health and treatments (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (1.2k citations), Orthopedics and Sports Medicine (230 citations) and Pulmonary and Respiratory Medicine (584 citations). Ronald Yanagihara has collaborated with scholars based in United States, Poland and Australia. Frequent co-authors include Lee S. Rosen, David Gordon, Vera Hirsh, Ming Zheng, Gladys Urbanowitz, Paul de Souza, Maciej Krzakowski, Marek Pawlicki, Dirk J. Reitsma and John J. Seaman. Their work appears in journals such as Journal of Clinical Oncology, Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.